Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Spinal Cord Stimulation | 19 | 2024 | 37 | 7.140 |
Why?
|
| Diabetic Neuropathies | 6 | 2023 | 49 | 4.240 |
Why?
|
| Chronic Pain | 15 | 2024 | 171 | 3.030 |
Why?
|
| Diabetes Mellitus | 5 | 2023 | 279 | 2.840 |
Why?
|
| Pain Management | 12 | 2024 | 164 | 1.760 |
Why?
|
| Electric Stimulation Therapy | 5 | 2023 | 23 | 1.340 |
Why?
|
| Pain Measurement | 6 | 2024 | 246 | 1.260 |
Why?
|
| Deep Brain Stimulation | 8 | 2020 | 43 | 1.210 |
Why?
|
| Neuralgia | 4 | 2024 | 63 | 0.970 |
Why?
|
| Neurosurgical Procedures | 7 | 2022 | 121 | 0.910 |
Why?
|
| Complex Regional Pain Syndromes | 2 | 2020 | 13 | 0.890 |
Why?
|
| Disabled Persons | 1 | 2023 | 76 | 0.810 |
Why?
|
| Treatment Outcome | 18 | 2024 | 5178 | 0.760 |
Why?
|
| Faculty | 1 | 2020 | 72 | 0.700 |
Why?
|
| Anesthesiology | 1 | 2020 | 45 | 0.690 |
Why?
|
| Education, Distance | 1 | 2020 | 41 | 0.690 |
Why?
|
| Stereotaxic Techniques | 4 | 2022 | 37 | 0.660 |
Why?
|
| Subthalamic Nucleus | 4 | 2011 | 12 | 0.630 |
Why?
|
| Humans | 43 | 2024 | 49922 | 0.580 |
Why?
|
| Parkinson Disease | 4 | 2011 | 141 | 0.540 |
Why?
|
| Pandemics | 2 | 2020 | 566 | 0.540 |
Why?
|
| Pedunculopontine Tegmental Nucleus | 1 | 2014 | 24 | 0.470 |
Why?
|
| Quality of Life | 7 | 2024 | 838 | 0.460 |
Why?
|
| Peripheral Nerves | 1 | 2014 | 48 | 0.460 |
Why?
|
| Balamuthia mandrillaris | 1 | 2012 | 2 | 0.420 |
Why?
|
| Amebiasis | 1 | 2012 | 6 | 0.410 |
Why?
|
| Pain | 3 | 2023 | 374 | 0.410 |
Why?
|
| Granuloma | 1 | 2012 | 45 | 0.400 |
Why?
|
| Encephalitis | 1 | 2012 | 40 | 0.400 |
Why?
|
| Ganglia, Spinal | 3 | 2020 | 52 | 0.370 |
Why?
|
| Failed Back Surgery Syndrome | 2 | 2021 | 2 | 0.340 |
Why?
|
| Magnetic Resonance Imaging | 7 | 2022 | 1526 | 0.330 |
Why?
|
| Middle Aged | 13 | 2024 | 12289 | 0.310 |
Why?
|
| Prospective Studies | 4 | 2023 | 2345 | 0.300 |
Why?
|
| Aged | 9 | 2024 | 9448 | 0.290 |
Why?
|
| Practice Guidelines as Topic | 2 | 2020 | 458 | 0.270 |
Why?
|
| Salvage Therapy | 2 | 2024 | 136 | 0.270 |
Why?
|
| Adult | 11 | 2024 | 13355 | 0.260 |
Why?
|
| Spinal Cord | 5 | 2024 | 174 | 0.260 |
Why?
|
| Follow-Up Studies | 2 | 2021 | 2177 | 0.250 |
Why?
|
| Female | 14 | 2024 | 26571 | 0.240 |
Why?
|
| Male | 13 | 2024 | 25450 | 0.230 |
Why?
|
| Pain, Intractable | 1 | 2024 | 6 | 0.230 |
Why?
|
| Nerve Block | 1 | 2024 | 39 | 0.230 |
Why?
|
| Cross-Over Studies | 1 | 2024 | 223 | 0.220 |
Why?
|
| Injections, Spinal | 2 | 2020 | 19 | 0.210 |
Why?
|
| Health Care Costs | 1 | 2023 | 168 | 0.200 |
Why?
|
| Back Pain | 2 | 2023 | 38 | 0.200 |
Why?
|
| Medicare | 1 | 2023 | 245 | 0.190 |
Why?
|
| Sex Factors | 2 | 2020 | 691 | 0.190 |
Why?
|
| Evidence-Based Medicine | 3 | 2017 | 247 | 0.190 |
Why?
|
| Electrodes, Implanted | 5 | 2014 | 29 | 0.190 |
Why?
|
| Dermatitis, Allergic Contact | 1 | 2021 | 11 | 0.190 |
Why?
|
| Drug Delivery Systems | 2 | 2020 | 143 | 0.180 |
Why?
|
| Health Occupations | 1 | 2020 | 19 | 0.180 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2023 | 550 | 0.180 |
Why?
|
| Industry | 1 | 2020 | 17 | 0.180 |
Why?
|
| Neurosurgery | 2 | 2018 | 33 | 0.180 |
Why?
|
| Critical Pathways | 1 | 2020 | 37 | 0.180 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2023 | 338 | 0.170 |
Why?
|
| Physicians, Women | 1 | 2020 | 22 | 0.170 |
Why?
|
| Physicians | 1 | 2023 | 229 | 0.170 |
Why?
|
| Neurology | 1 | 2020 | 36 | 0.170 |
Why?
|
| Societies, Medical | 1 | 2020 | 177 | 0.170 |
Why?
|
| Fellowships and Scholarships | 1 | 2020 | 118 | 0.170 |
Why?
|
| Off-Label Use | 1 | 2019 | 25 | 0.160 |
Why?
|
| Physician's Role | 1 | 2019 | 48 | 0.160 |
Why?
|
| Social Media | 1 | 2020 | 98 | 0.160 |
Why?
|
| Faculty, Medical | 1 | 2019 | 92 | 0.150 |
Why?
|
| Headache | 2 | 2015 | 75 | 0.150 |
Why?
|
| Career Choice | 1 | 2019 | 110 | 0.150 |
Why?
|
| Internet | 1 | 2020 | 261 | 0.150 |
Why?
|
| General Surgery | 1 | 2019 | 106 | 0.150 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 170 | 0.140 |
Why?
|
| United States | 3 | 2023 | 4880 | 0.140 |
Why?
|
| Movement Disorders | 2 | 2014 | 14 | 0.140 |
Why?
|
| Students, Medical | 1 | 2019 | 159 | 0.140 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 179 | 0.140 |
Why?
|
| Evoked Potentials | 2 | 2022 | 72 | 0.140 |
Why?
|
| Spinal Nerves | 1 | 2015 | 10 | 0.130 |
Why?
|
| Cross-Sectional Studies | 1 | 2020 | 1574 | 0.120 |
Why?
|
| Implantable Neurostimulators | 1 | 2014 | 1 | 0.120 |
Why?
|
| Headache Disorders | 1 | 2014 | 3 | 0.120 |
Why?
|
| Migraine Disorders | 1 | 2014 | 44 | 0.110 |
Why?
|
| Internship and Residency | 1 | 2019 | 442 | 0.110 |
Why?
|
| Mental Disorders | 1 | 2018 | 401 | 0.110 |
Why?
|
| Action Potentials | 2 | 2024 | 132 | 0.110 |
Why?
|
| Double-Blind Method | 2 | 2024 | 679 | 0.100 |
Why?
|
| Neurologic Examination | 1 | 2012 | 76 | 0.100 |
Why?
|
| Steroids | 1 | 2012 | 56 | 0.100 |
Why?
|
| Fatal Outcome | 1 | 2012 | 194 | 0.100 |
Why?
|
| Parietal Bone | 1 | 2011 | 2 | 0.090 |
Why?
|
| Polymerase Chain Reaction | 1 | 2012 | 456 | 0.090 |
Why?
|
| Neuronavigation | 1 | 2010 | 11 | 0.090 |
Why?
|
| Pneumocephalus | 1 | 2010 | 5 | 0.090 |
Why?
|
| Biopsy | 1 | 2012 | 591 | 0.090 |
Why?
|
| Surgery, Computer-Assisted | 1 | 2010 | 54 | 0.090 |
Why?
|
| Anesthesia | 1 | 2010 | 73 | 0.080 |
Why?
|
| Immunohistochemistry | 1 | 2012 | 972 | 0.080 |
Why?
|
| Analysis of Variance | 1 | 2010 | 552 | 0.080 |
Why?
|
| Adolescent | 1 | 2020 | 6416 | 0.080 |
Why?
|
| Reproducibility of Results | 2 | 2023 | 1182 | 0.080 |
Why?
|
| Child | 1 | 2020 | 6848 | 0.080 |
Why?
|
| Vagus Nerve Stimulation | 2 | 2020 | 12 | 0.070 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2012 | 1153 | 0.070 |
Why?
|
| Anti-Bacterial Agents | 1 | 2012 | 742 | 0.070 |
Why?
|
| Analgesics | 2 | 2019 | 100 | 0.070 |
Why?
|
| Single-Blind Method | 1 | 2024 | 115 | 0.060 |
Why?
|
| Demography | 1 | 2024 | 93 | 0.060 |
Why?
|
| Pain, Postoperative | 1 | 2024 | 157 | 0.050 |
Why?
|
| Consensus | 1 | 2024 | 155 | 0.050 |
Why?
|
| Brain | 1 | 2010 | 1310 | 0.050 |
Why?
|
| Patch Tests | 1 | 2021 | 6 | 0.050 |
Why?
|
| International Classification of Diseases | 1 | 2021 | 63 | 0.050 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2022 | 152 | 0.050 |
Why?
|
| Young Adult | 1 | 2010 | 4031 | 0.050 |
Why?
|
| Prostheses and Implants | 1 | 2021 | 54 | 0.050 |
Why?
|
| Erythema | 1 | 2021 | 38 | 0.050 |
Why?
|
| Spine | 1 | 2021 | 91 | 0.040 |
Why?
|
| Device Removal | 1 | 2021 | 84 | 0.040 |
Why?
|
| Curriculum | 1 | 2023 | 397 | 0.040 |
Why?
|
| Patient Safety | 1 | 2020 | 102 | 0.040 |
Why?
|
| Animals | 1 | 2014 | 13100 | 0.040 |
Why?
|
| United States Food and Drug Administration | 1 | 2019 | 91 | 0.040 |
Why?
|
| Retrospective Studies | 1 | 2010 | 6124 | 0.040 |
Why?
|
| Health Status | 1 | 2020 | 298 | 0.040 |
Why?
|
| Analgesics, Opioid | 1 | 2023 | 554 | 0.040 |
Why?
|
| Risk Factors | 2 | 2020 | 3604 | 0.040 |
Why?
|
| Time Factors | 1 | 2024 | 2891 | 0.040 |
Why?
|
| Risk Assessment | 1 | 2020 | 1254 | 0.030 |
Why?
|
| Reoperation | 1 | 2017 | 454 | 0.030 |
Why?
|
| Facial Pain | 1 | 2014 | 9 | 0.030 |
Why?
|
| Transcranial Magnetic Stimulation | 1 | 2014 | 69 | 0.030 |
Why?
|
| Ultrasonography, Interventional | 1 | 2014 | 137 | 0.030 |
Why?
|
| Patient Selection | 1 | 2014 | 254 | 0.030 |
Why?
|
| Anticoagulants | 1 | 2014 | 254 | 0.020 |
Why?
|
| Microelectrodes | 1 | 2010 | 21 | 0.020 |
Why?
|
| Beta Rhythm | 1 | 2010 | 2 | 0.020 |
Why?
|
| Electrophysiological Phenomena | 1 | 2010 | 18 | 0.020 |
Why?
|
| Electric Stimulation | 1 | 2010 | 117 | 0.020 |
Why?
|
| Intraoperative Period | 1 | 2010 | 45 | 0.020 |
Why?
|
| Software | 1 | 2010 | 274 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2010 | 953 | 0.020 |
Why?
|
| Postoperative Complications | 1 | 2010 | 1018 | 0.010 |
Why?
|